Marekani - Kiingereza - NLM (National Library of Medicine)

cosette pharmaceuticals, inc. - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg) - gentamicin 1 mg in 1 g - primary skin infections: impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. secondary skin infections: infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial super-infections of fungal or viral infections. please note: gentamicin sulfate is a bactericidal agent that is not effective against viruses or fungi in skin infections. gentamicin sulfate is useful in the treatment of infected skin cysts and certain other skin abscesses when preceded by incision and drainage to permit adequate contact between the antibiotic and the infecting bacteria. good results have been obtained in the treatment of infected stasis and other skin ulcers, infected superficial burns, paronychia, infected insect bites and stings, infected lacerations and abrasions, and wounds from minor surgery. patients sensitive to neomycin can be treated wi

Marekani - Kiingereza - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - gentamicin (unii: t6z9v48ikg) (gentamicin - unii:t6z9v48ikg) - gentamicin 1 mg in 1 g - primary skin infections: impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. secondary skin infections: infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial super-infections of fungal or viral infections. please note: gentamicin sulfate is a bactericidal agent that is not effective against viruses or fungi in skin infections. gentamicin sulfate is useful in the treatment of infected skin cysts and certain other skin abscesses when preceded by incision and drainage to permit adequate contact between the antibiotic and the infecting bacteria. good results have been obtained in the treatment of infected stasis and other skin ulcers, infected superficial burns, paronychia, infected insect bites and stings, infected lacerations and abrasions, and wounds from minor surgery. patients sensitive to neomycin can be treated wi

Marekani - Kiingereza - NLM (National Library of Medicine)

hospira, inc. - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg) - gentamicin 40 mg in 1 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of gentamicin and other antibacterial drugs, gentamicin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. gentamicin sulfate injection, usp is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: pseudomonas aeruginosa , proteus species (indole-positive and indole-negative), escherichia coli , klebsiella-enterobacter-serratia species, citrobacter species, and staphylococcus species (coagulase-positive and coagulase-negative). clinical studies have shown gentamicin sulfate injection, usp to be effective in bacterial neonatal seps

Malesia - Kiingereza - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hoe pharmaceuticals sdn. bhd. - gentamicin sulphate -

Israeli - Kiingereza - Ministry of Health

teva israel ltd - gentamicin as sulfate - solution for injection - gentamicin as sulfate 40 mg / 1 ml - gentamicin - gentamicin is indicated in bacteremia, urinary tract infections, endocarditis, chest infections and other serious systemic infections due to confirmed or expected bacteria that are susceptible to gentamicin, in adults and children, including neonates.

Namibia - Kiingereza - Namibia Medicines Regulatory Council

t. van der walt - gentamicin sulphate eqivalent to 80 mg base - injectable solution - gentamicin sulphate eqivalent to 80 mg base

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - gentamicin - solution for infusion - 3 milligram(s)/millilitre - other aminoglycosides; gentamicin

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - gentamicin - solution for infusion - 1 milligram(s)/millilitre - other aminoglycosides; gentamicin

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

pharmexon consulting s.r.o - gentamicin sulfate - solution for injection/infusion - 40 milligram(s)/millilitre - other aminoglycosides; gentamicin

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

panpharma - gentamicin sulfate - solution for injection/infusion - 40 milligram(s)/millilitre - other aminoglycosides; gentamicin